Immunological manipulation of adiposity

Perspectives on ruminant nutrition and metabolism. II. Metabolism in ruminant tissues

The discovery of the dominance of short-chain fatty acids as energy sources in the 1940s and 1950s, as discussed in part I of this review (Annison & Bryden, 1998) led to uncertainties concerning the interrelationships of glucose and acetate in ruminant metabolism. These were resolved in the following decade largely by use of14C-labelled substrates. Although only small amounts of glucose are absorbed in most dietary situations, glucose availability to ruminant tissues as measured by isotope dilution was shown to be substantial, indicating that gluconeogenesis is a major metabolic activity in both fed and fasted states. Studies with14C-labelled glucose and acetate revealed that in contrast to non-ruminants, acetate and not glucose is the major precursor of long-chain fatty acids in ruminant tissues. Interest in the measurement of energy metabolism in livestock grew rapidly from the 1950s. Most laboratories adopted indirect calorimetry and precise measurements of the energy expenditure of ruminants contributed to the development of new feeding systems. More recently, alternative approaches to the measurement of energy expenditure have included the use of NMR spectroscopy, isotope dilution and the application of the Fick principle to measure O2consumption in the whole animal and in defined tissues. The refinement of the classical arterio-venous difference procedure in the study of mammary gland metabolism in the 1960s, particularly when combined with isotope dilution, encouraged the use of these methods to generate quantitative data on the metabolism of a range of defined tissues. The recent introduction of new methods for the continuous monitoring of both blood flow and blood O2content has greatly increased the precision and scope of arterio-venous difference measurements. The impact of data produced by these and other quantitative procedures on current knowledge of the metabolism of glucose, short-chain fatty acids and lipids, and on N metabolism, is outlined. The role of the portal-drained viscera and liver in N metabolism is discussed in relation to data obtained by the use of multi-catheterized animals. Protein turnover, and the impact of stress (physical, social and disease related) on protein metabolism have been reviewed. The growth of knowledge of mammary gland metabolism and milk synthesis since the first quantitative studies in the 1960s has been charted. Recent findings on the regulation of amino acid uptake and utilization by the mammary gland, and on the control of milk secretion, are of particular interest and importance.

Pharmacological approaches for the treatment of obesity

The high incidence of obesity, its multifactorial nature, the complexity and lack of knowledge of the bodyweight control system, and the scarcity of adequate therapeutics have fuelled anti-obesity drug development during a considerable number of years. Irrespective of the efforts invested by researchers and companies, few products have reached a minimum level of effectiveness, and even fewer are available in medical practice. As a consequence of anti-obesity research, our knowledge of the bodyweight control system increased but, despite this, the pharmacological approaches to the treatment of obesity have not resulted yet in effective drugs. This review provides a panoramic of the multiple different approaches developed to obtain workable drugs. These approaches, however, rely in only four main lines of action: control of energy intake, mainly through modification of appetite;control of energy expenditure, essentially through the increase of thermogenesis;control of the availability of substrates to cells and tissues through hormonal and other metabolic factors controlling the fate of the available energy substrates; andcontrol of fat reserves through modulation of lipogenesis and lipolysis in white adipose tissue. A large proportion of current research is centred on neuropeptidic control of appetite, followed by the development of drugs controlling thermogenic mechanisms and analysis of the factors controlling adipocyte growth and fat storage. The adipocyte is also a fundamental source of metabolic signals, signals that can be intercepted, modulated and used to force the brain to adjust the mass of fat with the physiological means available. The large variety of different approaches used in the search for effective anti-obesity drugs show both the deep involvement of researchers on this field and the large amount of resources devoted to this problem by pharmaceutical companies. Future trends in anti-obesity drug research follow closely the approaches outlined; however, the increasing mass of information on the molecular basis of bodyweight control and obesity will in the end prevail in our search for effective and harmless anti-obesity drugs.

Isolation and tissue profiles of a large panel of phage antibodies binding to the human adipocyte cell surface

Phage display is a powerful technique for the rapid selection and isolation of antibodies to any given target antigen. We have applied this technology to isolate over 100 different human antibodies that bind to antigens expressed in situ on the human adipocyte cell surface. This is a diverse panel of antibodies, as indicated by the V-region sequences. The binding profile of each anti-adipocyte antibody has been characterised using phage antibody immunocytochemistry against a panel of normal human tissues. Although there was some variation in the intensity of the adipocyte staining, each antibody consistently recognised adipocytes, where present, irrespective of the tissue source. In addition, all of the antibodies recognised at least one other cell type other than the adipocyte cell surface. In total, over 50 different tissue-binding profiles were recorded, with the most frequently recognised tissues identified as capillaries or smooth muscle. Extensive tissue binding profiles were generated for some antibodies using a panel of 37 different human tissues. This identified anti-adipocyte antibodies with unexpected profiles, such as FAT.13, which binds only to adipocytes and capillaries in the entire tissue panel. We believe this is the most extensive survey ever undertaken of the human adipocyte cell surface. Moreover, similar methodology could be used to derive complete tissue-binding profiles of antibodies against cell-surface antigens of any cell type. Indeed, by screening antibodies on both normal and diseased tissues, it may be possible to identify antigenic associations between different cell types and the pathologies of many diseases.